Xenetic Biosciences (XBIOW) Short Interest Ratio & Short Volume → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free XBIOW Stock Alerts $7.46 -0.68 (-8.35%) (As of 04/9/2024) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Xenetic Biosciences Short Interest DataCurrent Short Volume200 sharesPrevious Short Volume400 sharesChange Vs. Previous Month-50.00%Dollar Volume Sold Short$1,492.00Short Interest Ratio / Days to Cover0.7Last Record DateApril 15, 2024Today's Trading Volume100 sharesAverage Trading Volume688 sharesToday's Volume Vs. Average15% Short Selling Xenetic Biosciences ? Sign up to receive the latest short interest report for Xenetic Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatXBIOW Short Interest Over TimeXBIOW Days to Cover Over TimeXBIOW Percentage of Float Shorted Over Time Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report Xenetic Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024200 shares $1,492.00 -50.0%N/A0.7 $7.46 3/31/2024400 shares $5,880.00 No ChangeN/A1.3 $14.70 3/15/2024400 shares $5,880.00 +33.3%N/A1.3 $14.70 2/29/2024300 shares $3,255.00 +200.0%N/A1 $10.85 2/15/2024100 shares $940.00 No ChangeN/A0.5 $9.40 1/31/2024100 shares $950.00 No ChangeN/A0.5 $9.50 XBIOW Short Interest - Frequently Asked Questions What is Xenetic Biosciences' current short interest? Short interest is the volume of Xenetic Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 200 shares of XBIOW short. Learn More on Xenetic Biosciences' current short interest. What is a good short interest ratio for Xenetic Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XBIOW shares currently have a short interest ratio of 1.0. Learn More on Xenetic Biosciences's short interest ratio. Is Xenetic Biosciences' short interest increasing or decreasing? Xenetic Biosciences saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 200 shares, a decline of 50.0% from the previous total of 400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Xenetic Biosciences stock? Short selling XBIOW is an investing strategy that aims to generate trading profit from Xenetic Biosciences as its price is falling. XBIOW shares are trading down $0.68 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Xenetic Biosciences? A short squeeze for Xenetic Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of XBIOW, which in turn drives the price of the stock up even further. How often is Xenetic Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XBIOW, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ATNFW Short Squeeze DRTSW Short Squeeze APLMW Short Squeeze ARTLW Short Squeeze BCTXW Short Squeeze CDIOW Short Squeeze CTCXW Short Squeeze SAVAW Short Squeeze CELUW Short Squeeze CLNNW Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XBIOW) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace